We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Blood Tests for Detecting Antioxidant and Inflammation Levels Could Diagnose Breast Cancer

By LabMedica International staff writers
Posted on 07 Apr 2022
Print article
Image: Antioxidant, inflammation levels may reveal new diagnostic tool for breast cancer (Photo courtesy of Pexels)
Image: Antioxidant, inflammation levels may reveal new diagnostic tool for breast cancer (Photo courtesy of Pexels)

Breast cancer is the most prevalent cancer in the world. Identifying new diagnostic techniques is of major importance to efforts that aim to minimize the disease’s devastating effects. Now, a new study that analyzes levels of antioxidants and stress markers in the blood could lead to a new diagnostic tool for breast cancer.

Researchers from the University of Lahore (Lahore, Pakistan) explored the role that inflammatory and stress markers may play in the development and progression of breast cancer. The research team examined blood samples from premenopausal women diagnosed with breast cancer. When compared to age-matched controls without cancer, the breast cancer patients had significantly increased levels of inflammatory markers.

Among the overexpressed markers were the pro-inflammatory protein interleukin-1, matrix metalloproteinase 9 - an enzyme that is overexpressed in several diseases - and heat shock protein 27. This protein acts as an antioxidant that typically prevents or reduces cell death. However, in some disease states - such as cancer - heat shock protein 27 has been found to be both protective and destructive. In addition, the breast cancer group had low levels of protective compounds such as vitamins A, C and D, catalase - an enzyme that protects cells from oxidative stress - and the antioxidants superoxide dismutase and glutathione.

“The breast cancer pathophysiology included an overbalance of oxidants or stress markers and an underbalance of antioxidants,” said Samina Malik, MBBS, MPhil, first author of the study. This proportion of pro- and anti-inflammatory components may play “a crucial role in the metastasis of breast cancer” and may be useful as a diagnostic marker for the disease, according to the researchers.

Related Links:
University of Lahore 

Automated ELISA-IFA-BLOT Processor AP 22
Gold Supplier
SARS-CoV-2 Antigen Test
NG-Test SARS-NG-Test SARS-CoV-2 Ag Cassette
New
Gold Supplier
Automated Chemiluminescent Analyzer
QUANTA Flash M2 (MIT3)
New
WBC Analyzer
HemoCue WBC System

Print article

Channels

Molecular Diagnostics

view channel
Image: A new method reliably detects protein changes in blood that are typical of Parkinson`s disease (Photo courtesy of Pexels)

First-Ever Blood Test Detects Parkinson’s Disease

Until now, the diagnosis of Parkinson's disease has been based primarily on typical movement disorders such as muscle stiffness, slower movements and shaking. However, the disease starts up to 20 years... Read more

Industry

view channel
Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.